FDA Adverse Event Injury Summary report: N

XEN 45 GTS

MDR report key: 11267794 · Received February 2, 2021

Report

Report Number
3011299751-2021-00010
Event Type
Injury
Date Received
February 2, 2021
Date of Event
December 8, 2020
Report Date
February 2, 2021
Manufacturer
ALLERGAN (IRVINE)
Product Code
KYF
PMA / PMN Number
K161457
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
DA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

ARTICLE CITATION: OLSEN, LENE PODER. ¿IMPLANTATION OF THE XEN®45 GEL STENT IN PATIENTS WITH GLAUCOMA AT A UNIVERSITY HOSPITAL ¿ A RETROSPECTIVE QUALITY CONTROL STUDY.¿ ACTA OPHTHALMOLOGICA, LETTER TO THE EDITOR, 08 DECEMBER 2020, E-PUB AHEAD OF PRINT, DOI:10.1111/AOS.14684. A REVIEW OF THE DEVICE HISTORY RECORD HAS BEEN INITIATED. IF ANY NEW, CHANGED OR CORRECTED INFORMATION IS NOTED, A SUPPLEMENTAL MEDWATCH WILL BE SUBMITTED. THE EVENT OF SCLERITIS IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT.

Description of Event or Problem · 1

REPORTED EVENTS OF NECROTIZING SCLERITIS IN THE LEFT EYE WERE NOTED IN THE ARTICLE: ¿IMPLANTATION OF THE XEN®45 GEL STENT IN PATIENTS WITH GLAUCOMA AT A UNIVERSITY HOSPITAL ¿ A RETROSPECTIVE QUALITY CONTROL STUDY,¿ ACTA OPTHALMOLOGICA, E-PUB AHEAD OF PRINT - 8DEC2020. AFTER MONTHS OF TOPICAL BROAD ANTIBIOTICS, SYSTEMIC PREDNISOLONE AND SURGICAL REVISION OF THE NECROSIS AND NECROTIC AREA THEN SUTURING OF PERICARDIAC TISSUE OVER THE THIN SCLERA, AND COVERED WITH CONJUNCTIVA, THE EVENT HAS BEEN RESOLVED. REPORTED EVENTS ARE ASSOCIATED WITH ONE PATIENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
162120 XEN 45 GTS IMPLANT, EYE VALVE KYF ALLERGAN (IRVINE) 62031

Patients

Seq Age Sex Outcome Treatment
1 77 YR Required Intervention